Turek-Jakubowska, A.; Dębski, J.; Jakubowski, M.; Szahidewicz-Krupska, E.; Gawryś, J.; Gawryś, K.; Janus, A.; Trocha, M.; Doroszko, A.
New Candidates for Biomarkers and Drug Targets of Ischemic Stroke—A First Dynamic LC-MS Human Serum Proteomic Study. J. Clin. Med. 2022, 11, 339.
https://doi.org/10.3390/jcm11020339
AMA Style
Turek-Jakubowska A, Dębski J, Jakubowski M, Szahidewicz-Krupska E, Gawryś J, Gawryś K, Janus A, Trocha M, Doroszko A.
New Candidates for Biomarkers and Drug Targets of Ischemic Stroke—A First Dynamic LC-MS Human Serum Proteomic Study. Journal of Clinical Medicine. 2022; 11(2):339.
https://doi.org/10.3390/jcm11020339
Chicago/Turabian Style
Turek-Jakubowska, Aleksandra, Janusz Dębski, Maciej Jakubowski, Ewa Szahidewicz-Krupska, Jakub Gawryś, Karolina Gawryś, Agnieszka Janus, Małgorzata Trocha, and Adrian Doroszko.
2022. "New Candidates for Biomarkers and Drug Targets of Ischemic Stroke—A First Dynamic LC-MS Human Serum Proteomic Study" Journal of Clinical Medicine 11, no. 2: 339.
https://doi.org/10.3390/jcm11020339
APA Style
Turek-Jakubowska, A., Dębski, J., Jakubowski, M., Szahidewicz-Krupska, E., Gawryś, J., Gawryś, K., Janus, A., Trocha, M., & Doroszko, A.
(2022). New Candidates for Biomarkers and Drug Targets of Ischemic Stroke—A First Dynamic LC-MS Human Serum Proteomic Study. Journal of Clinical Medicine, 11(2), 339.
https://doi.org/10.3390/jcm11020339